MTNB - What's Going On With Matinas Biopharma Holdings Stock? | Benzinga
Matinas Biopharma Holdings, Inc. (AMEX:MTNB) shares are trading higher on Wednesday after the company announced complete clinical resolution of a patient's recurrent hemorrhagic cystitis following treatment with MAT2203.
The Details:
The company announced the complete clinical resolution of a patient's recurrent hemorrhagic cystitis due to Candida krusei (C. krusei), a fluconazole inherited resistant fungal pathogen, following treatment with MAT2203, an oral formulation of the potent antifungal amphotericin B.
The patient was ...